Your browser doesn't support javascript.
loading
An online alpha-thalassemia carrier discrimination model based on random forest and red blood cell parameters for low HbA2 cases.
Feng, Pinning; Li, Yuzhe; Liao, Zhihao; Yao, Zhenrong; Lin, Wenbin; Xie, Shuhua; Hu, Beini; Huang, Chencui; Liu, Wei; Xu, Hongxu; Liu, Min; Gan, Wenjia.
Afiliação
  • Feng P; Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Li Y; Department of Clinical Laboratory, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Liao Z; Department of Clinical Laboratory, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Yao Z; Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Lin W; Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Xie S; Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Hu B; R&D Center, Beijing Deepwise & League of PHD Technology Co., Ltd, Beijing, China.
  • Huang C; R&D Center, Beijing Deepwise & League of PHD Technology Co., Ltd, Beijing, China.
  • Liu W; R&D Center, Beijing Deepwise & League of PHD Technology Co., Ltd, Beijing, China.
  • Xu H; Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
  • Liu M; Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Electronic address: liumin@mail.sysu.edu.cn.
  • Gan W; Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China. Electronic address: ganwj3@mail.sysu.edu.cn.
Clin Chim Acta ; 525: 1-5, 2022 Jan 15.
Article em En | MEDLINE | ID: mdl-34883090
ABSTRACT

BACKGROUND:

Since screening of α-thalassemia carriers by low HbA2 has a low positive predictive value (PPV), the PPV was as low as 40.97% in our laboratory, other more effective screening methods need to be devised. This study aimed at developing a machine learning model by using red blood cell parameters to identify α-thalassemia carriers from low HbA2 patients.

METHODS:

Laboratory data of 1213 patients with low HbA2 used for modeling was randomly divided into the training set (849 of 1213, 70%) and the internal validation set (364 of 1213, 30%). In addition, an external data set (n = 399) was used for model validation. Fourteen machine learning methods were applied to construct a discriminant model. Performance was evaluated with accuracy, sensitivity, specificity, etc. and compared with 7 previously published discriminant function formulae.

RESULTS:

The optimal model was based on random forest with 5 clinical features. The PPV of the model was more than twice the PPV of HbA2, and the model had a high negative predictive value (NPV) at the same time. Compared with seven formulae in screening of α-thalassemia carriers, the model had a better accuracy (0.915), specificity (0.967), NPV (0.901), PPV (0.942) and area under the receiver operating characteristic curve (AUC, 0.948) in the independent test set.

CONCLUSION:

Use of a random forest-based model enables rapid discrimination of α-thalassemia carriers from low HbA2 cases.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talassemia beta / Talassemia alfa Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Talassemia beta / Talassemia alfa Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article